in this issue
Regions :: North America
Cytec beats estimates as sales rise slightly
3:29 PM MDT | October 17, 2013 | Vincent Valk
Cytec has reported third-quarter net earnings of $43.8 million, or $1.19/share, down 25% year-on-year (YOY), with sales from continuing operations totaling $464 million, up 2%. Excluding charges and discontinued operations, adjusted earnings from continuing operations totaled $49.4 million, or $1.34/share, up 6% and slightly ahead of analysts’ consensus estimate of $1.32/share, as reported by Thomson Reuters (New York). “Our third quarter results reflect more modest top line growth compared to the third quarter of last year as legacy large commercial...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee